KEGG pathway enrichment highlighted Pathways in Cancer, MAPK signaling, and PI3K-Akt signaling, linking targets to oncogenic signaling and metabolic disease mechanisms (Figure 4E) (Wu et al., 2025; Muraleva and Kolosova, 2023). This evidence concerns the gene AKT1 and metabolic disease.